CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration

(2013) Tien-Huang Lin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine

(2013) Simona Principe et al.   PROTEOMICS

Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer

(2012) Suguru Shirotake et al.   AMERICAN JOURNAL OF PATHOLOGY

CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer

(2012) Manisha Agarwal et al.   PROSTATE

Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy

(2011) Qinwen Wang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prioritizing genes associated with prostate cancer development

(2010) Ivan P Gorlov et al.   BMC CANCER

The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population

(2010) Mo Shen et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Chemokines and chemokine receptors: an overview

(2009) Raffaella Bonecchi   Frontiers in Bioscience-Landmark

Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner

(2009) L. Izhak et al.   JOURNAL OF IMMUNOLOGY

Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy

(2008) D. L. Blum et al.   CLINICAL CANCER RESEARCH

Multi-faceted roles for CXC-chemokines in prostate cancer progression

(2008) David et al.   Frontiers in Bioscience-Landmark

Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer

(2008) Pirus Ghadjar et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA

(2008) Jill A. Macoska et al.   PROSTATE